Valeant Pharmaceuticals acquires DermaTech
Valeant Pharmaceuticals International today announced that it has acquired DermaTech Pty Ltd, an Australian specialty pharmaceutical company focused on dermatology products marketed throughout Australia and overseas, for approximately AU$19 million, with customary adjustments for net asset value.
California-based pharmaceuticals company Valeant Pharmaceuticals International has acquired privately-held Swiss generic drugs firm PharmaSwiss for US$480 million.